Star Combo Pharma logo

S66 - Star Combo Pharma Share Price

A$0.29 0.0  0.0%

Last Trade - 25/02/21

Sector
Consumer Cyclicals
Size
Micro Cap
Market Cap £22.2m
Enterprise Value £10.3m
Revenue £22.0m
Position in Universe 1162nd / 1831
Bullish
Bearish
Unlock S66 Revenue
Momentum
Relative Strength (%)
1m -2.32%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -47.3%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
6.70 9.40 9.84 10.9 21.6 39.1 +42.3%
-41.9 +670 -10.1
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 31 December 2020, StarCombo Pharma Ltd revenues decreased 30% to A$14.7M. Netincome totaled A$530K vs. loss of A$1.2M. Revenues reflectAustoyou retail segment decrease of 43% to A$8.6M, China(Country) segment decrease of 45% to A$5.8M, Australia(Country) segment decrease of 18% to A$8.6M. Net Incomereflects Administrative expenses decrease of 13% to A$2M(expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

S66 Revenue Unlock S66 Revenue

Net Income

S66 Net Income Unlock S66 Revenue

Normalised EPS

S66 Normalised EPS Unlock S66 Revenue

PE Ratio Range

S66 PE Ratio Range Unlock S66 Revenue

Dividend Yield Range

S66 Dividend Yield Range Unlock S66 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
S66 EPS Forecasts Unlock S66 Revenue
Profile Summary

Star Combo Pharma Limited is an Australia-based company that provides nutritional products. The Company develops, manufactures and distributes a range of vitamins, dietary supplements and skincare products. It sells the products under various brands, including Costar, Amax, J&K and Living Healthy. Its products include Costar Royal Jelly, Costar Lanolin and VE Cream, Costar Propolis and Costar Colostrum. It manufactures and distributes its health products within Australia and across Asia. It also manufactures therapeutic goods for other pharmaceutical or nutritional brand owners. It sells its products in Australia through retail channels, such as souvenir, convenience and grocery stores, and Terry White pharmacy stores. It also sells products through its Website, as well as various online e-commerce platforms, such as Taobao and JD. Its subsidiaries include Star Combo Australia Pty Ltd and Costar Pharma Laboratory Pty Ltd.

Directors
Last Annual June 30th, 2020
Last Interim June 30th, 2020
Incorporated November 4, 2016
Public Since May 16, 2018
No. of Shareholders: 664
No. of Employees: n/a
Sector Consumer Cyclicals
Industry Specialty Retailers
Index
Exchange Australian Stock Exchange - SEATS
Shares in Issue 135,616,601
Free Float (0.0%)
Eligible for
ISAs
SIPPs
S66 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for S66
Upcoming Events for S66
Frequently Asked Questions for Star Combo Pharma
What is the Star Combo Pharma share price?

As of 25/02/21, shares in Star Combo Pharma are trading at A$0.29, giving the company a market capitalisation of £22.2m. This share price information is delayed by 15 minutes.

How has the Star Combo Pharma share price performed this year?

Shares in Star Combo Pharma are currently trading at A$0.29 and the price has moved by -42% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Star Combo Pharma price has moved by -44.57% over the past year.

What are the analyst and broker recommendations for Star Combo Pharma?

There are no analysts currently covering Star Combo Pharma.

When will Star Combo Pharma next release its financial results?

Star Combo Pharma is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Star Combo Pharma dividend yield?

Star Combo Pharma does not currently pay a dividend.

Does Star Combo Pharma pay a dividend?

Star Combo Pharma does not currently pay a dividend.

When does Star Combo Pharma next pay dividends?

Star Combo Pharma does not currently pay a dividend.

How do I buy Star Combo Pharma shares?

To buy shares in Star Combo Pharma you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Star Combo Pharma?

Shares in Star Combo Pharma are currently trading at A$0.29, giving the company a market capitalisation of £22.2m.

Where are Star Combo Pharma shares listed? Where are Star Combo Pharma shares listed?

Here are the trading details for Star Combo Pharma:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: S66
What kind of share is Star Combo Pharma?

Based on an overall assessment of its quality, value and momentum, Star Combo Pharma is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Star Combo Pharma share price forecast 2021?

We were not able to load any forecast data for Star Combo Pharma.

How can I tell whether the Star Combo Pharma share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Star Combo Pharma. Over the past six months, the relative strength of its shares against the market has been -29.19%. At the current price of A$0.29, shares in Star Combo Pharma are trading at -30.89% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Star Combo Pharma PE Ratio?

We were not able to find PE ratio data for Star Combo Pharma.

Who are the key directors of Star Combo Pharma?

We were unable to find the directors for Star Combo Pharma.

Who are the major shareholders of Star Combo Pharma?

Here are the top five shareholders of Star Combo Pharma based on the size of their shareholding:

Goldenstar Pharmaceutical Investment Ltd. Corporation
Percentage owned: 36.37% (49.0m shares)
Zhang (Jinxing) Individual Investor
Percentage owned: 28.33% (38.2m shares)
Zhang (Su) Individual Investor
Percentage owned: 8.5% (11.4m shares)
Lepu Medical (Europe) Cooperatief U.A. Corporation
Percentage owned: 8.17% (11.0m shares)
Certane Ct Pty. Ltd. Corporation
Percentage owned: 4.66% (6.28m shares)
Similar to S66
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.